
Ronny Gunnarsson, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg.
Photo Credit: Pernilla Häyhänen
Scientific Frontline: Extended "At a Glance" Summary: Antibiotic Efficacy in Preventing Invasive Streptococcal Infections
The Core Concept: Prescribing antibiotics for uncomplicated, acute sore throats has a negligible effect on preventing the population-level spread of potentially life-threatening invasive Group A streptococcus (iGAS) infections.
Key Distinction/Mechanism: While antibiotics are routinely debated as a preventive measure against iGAS, the infection's transmission dynamics render this approach highly ineffective. Most patients seek care after their peak contagious window, and up to 25% of iGAS cases are transmitted by asymptomatic carriers who would not trigger clinical intervention.
Major Frameworks/Components:
- Statistical Inefficacy: Even under an extreme theoretical model where every sore throat patient is tested and treated, only 6.7% of iGAS cases in children and 2.8% in adults could be prevented.
- Guideline Limitations: When adhering strictly to targeted diagnostic symptom guidelines (such as the Centor criteria), the maximum preventive effect drops to 1.6% in children and 1.2% in adults.
- Resource Burden: Preventing a single case of iGAS requires conducting between 45,000 and 110,000 throat swabs and dispensing up to 110,000 antibiotic prescriptions, which creates severe strain on primary care infrastructure and elevates the risk of widespread antibiotic side effects.


.png)



.jpg)



.png)







.jpg)